+

there is hope

THERE IS HOPE

A promising immune therapy may stop or slow down the autoimmune reaction that causes type 1 diabetes (T1D). Anti-CD3 may change the course of the disease in those with the highest risk of developing T1D.

THERE IS HOPE

After 20 years of clinical research in immune tolerance therapies researchers are getting closer to finding ways to delay or prevent type 1 diabetes.

Preventing T1D

After 20 years of clinical research in immune tolerance therapies researchers are getting closer to finding ways to delay or prevent type 1 diabetes. If you are related to someone with T1D, you are in a unique position to help.

Immunology 101

You can help

Interested in participating in the prevention trial? The first step is to find out if you have T1D antibodies. Read about who can get the free test and how Рon the trial page. Questions? Let us know.

Take Action

In the News

What are people saying about anti-CD3 immune therapy? Is the medical scientific community behind anti-CD3 for type 1 diabetes? Find links to press and journal articles that tell the story of anti-CD3.

News Stories